Context Therapeutics's total assets for Q3 2025 were $79.23M, a decrease of -9.09% from the previous quarter. CNTX total liabilities were $6.06M for the fiscal quarter, a 31.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.